1. Kokot F, Wigcek A (1989) Endocrine changes in chronic dialysis patients. In: Maher JF (ed) Replacement of renal function by dialysis. Kluwer, Dordrecht, pp 953–971
2. Kokot F, Wigcek A, Grzeszczak W, Klepacka J, Klin M (1989) Influence of erythropoietin treatment on endocrine abnormalities in haemodialyzed patients. In: Baldamus CA, Scigalla P, Wieczorek L, Koch KM (eds) Erythropoietin: from molecular structure to clinical application. Contrib Nephrol, Karger, Basel, pp 257–272
3. Kokot F, Wigcek A, Grzeszczak K, Klin M (1990) Influence of erythropoietin treatment on function of the pituitary adrenal axis and somatotropin secretion in hemodialyzed patients. Clin Nephrol 33: 241–246
4. Schaefer RM, Kokot F, Heidland A (1989) Impact of recombinant erythropoietin on sexual function in hemodialysis patients. In: Baldamus CA, Scigalla P, Wieczorek al, Koch KM (eds) Erythropoietin: from molecular structure to clinical application. Contrib Nephrol, Karger, Basel, pp 273–282
5. Schaefer RM, Kokot F, Kürner B, Zech M, Heidland A (1988) Normalization of elevated prolactin levels in hemodialysis patients on erythropoietin. Nephron 50: 400–401